期刊文献+

终止结核病流行须加强结核分枝杆菌潜伏感染高危人群筛查和预防性治疗的管理 被引量:28

To end tuberculosis epidemic needs strengthen the management of screening and preventive treatment of latent tuberculosis infection in high-risk groups
下载PDF
导出
摘要 当前,全球结核病发病率下降缓慢,给实现终止结核病目标带来了严峻的挑战。2020年估算全球结核分枝杆菌潜伏感染人群近20亿,在无预防性治疗干预情况下,其中有5%~10%的感染者在一生中会发展为活动性结核病,在结核病高危人群中发病率更高。世界卫生组织在全球范围内号召推广结核分枝杆菌潜伏感染(LTBI)的预防干预,以实现结核病发病率快速下降的目标。笔者就LTBI流行和预防性治疗的现状、高危人群发病风险、筛查方法、干预和管理建议等进行论述,为制定我国LTBI干预和管理策略及措施提供参考。 Currently,the slow decline of tuberculosis incidence rate becomes a huge challenge to the goal of ending tuberculosis.In 2020,the estimated global latent tuberculosis infection(LTBI)population was nearly 2 billion.With the condition of no preventive intervention,5%to 10%of them will develop into active tuberculosis in the lifetime,and the incidence rate is higher in high-risk population.The World Health Organization has called for the promotion of the prevention of LTBI worldwide,so as to achieve the goal of a rapid decline in the incidence rate of tuberculosis.This paper reviews the current situation of LTBI epidemic and preventive treatment,the incidence risk of high-risk population,screening methods,intervention and management suggestions,etc.,in order to provide reference for formulating LTBI intervention and management strategies and measures in China.
作者 马艳 陆伟 高磊 初乃惠 周林 成诗明 MA Yan;LU Wei;GAO Lei;CHU Nai-hui;ZHOU Lin;CHENG Shi-ming(Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Jiangsu Provincial Center for Disease Control and Prevention,Nanjing 210009,China;Institute of Pathogen Biology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100730,China;Department of Tuberculosis,Beijing Chest Hospital,Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing 101149,China;Department of Patient Care,National Center for Tuberculosis Control and Prevention,Chinese Center for Disease Control and Prevention,Beijing 102206,China;Chinese Antituberculosis Association,Beijing 100710,China)
出处 《中国防痨杂志》 CAS CSCD 2022年第3期209-214,共6页 Chinese Journal of Antituberculosis
基金 “十二五”国家科技重大专项(2014ZX10003002-004、2015ZX09108-003) “十三五”国家科技重大专项(2018ZX10731301、2020ZX09201001-005、2018ZX10103001-001-008、2017ZX10201301-001-003、2017ZX09304009)。
关键词 分枝杆菌 结核 传染病潜伏期 诊断 预防和防护用药 Mycobacterium tuberculosis Infectious disease incubation period Diagnosis Protective agents
  • 相关文献

参考文献10

二级参考文献97

  • 1刘玉清,屠德华,安燕生,张立兴.大学生结核病控制的研究:(二)结核感染者的预防性治疗[J].中国防痨杂志,2005,27(3):139-142. 被引量:94
  • 2葛广秀,彭义利,邱美玲,叶德普,伍学强,胡天勇,王国斌,刘桂兰,黄桂玲,汤金琴.结核菌素试验复强反应发生率及机理的探讨[J].中国防痨杂志,1995,17(4):173-175. 被引量:2
  • 3唐神结.菌阴肺结核患者的临床特征[J].中华结核和呼吸杂志,2005,28(10):674-676. 被引量:21
  • 4江载芳,赵顺英.儿童肺结核的临床诊断标准和治疗方案(试行)[J].中华儿科杂志,2006,44(4):249-251. 被引量:134
  • 5Harries AD, Lawn SD, Getahun H, et al. HIV and tuberculo-sis-science and implementation to turn the tide and reduce deaths. J Int AIDS Soc, 2012,15(2): 17396.
  • 6Padmapriyadarsini C, Narendran G, Swaminathan S. Diagnosis and treatment of tuberculosis in HIV co-infected patients. Indian J Med Res, 2011,134(6) : 850-865.
  • 7Lin WC, Lin HH, Lee SS, et al. Prevalence of latent tubercu- losis infection in persons with and without human immunodefi- ciency virus infection using two interferon-gamma release as- says and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country. J Microbiol Immunol Infect, 2014.
  • 8Redelman-Sidi G, Sepkowitz KA, Sepkowitz. IFN-gamma re- lease assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med, 2013,188(4): 422-431.
  • 9Ariga H, Harada N. [-Evolution of IGRA researches]. Kekkaku, 2008,83(9) :641-652.
  • 10Pai M, Zwerling A, Menzies D. Systematic review: T-cell- based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med, 2008, 149(3):177-184.

共引文献184

同被引文献239

引证文献28

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部